vs
和黄医药（HCM）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是和黄医药的1.2倍（$324.4M vs $270.8M），Revolve Group, Inc.净利率更高（5.7% vs 0.7%，领先5.0%），Revolve Group, Inc.同比增速更快（10.4% vs -16.5%），和黄医药自由现金流更多（$3.4M vs $-13.3M）
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
HCM vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.2倍
$270.8M
营收增速更快
RVLV
高出27.0%
-16.5%
净利率更高
RVLV
高出5.0%
0.7%
自由现金流更多
HCM
多$16.6M
$-13.3M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.8M | $324.4M |
| 净利润 | $2.0M | $18.6M |
| 毛利率 | 37.7% | 53.3% |
| 营业利润率 | -13.2% | 6.3% |
| 净利率 | 0.7% | 5.7% |
| 营收同比 | -16.5% | 10.4% |
| 净利润同比 | -83.6% | 50.4% |
| 每股收益（稀释后） | $0.00 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HCMRVLV
| Q4 25 | $270.8M | $324.4M | ||
| Q3 25 | — | $295.6M | ||
| Q2 25 | $277.7M | $309.0M | ||
| Q1 25 | $324.5M | $296.7M | ||
| Q4 24 | — | $293.7M | ||
| Q3 24 | — | $283.1M | ||
| Q2 24 | $305.7M | $282.5M | ||
| Q1 24 | — | $270.6M |
净利润HCMRVLV
| Q4 25 | $2.0M | $18.6M | ||
| Q3 25 | — | $21.2M | ||
| Q2 25 | $455.0M | $10.2M | ||
| Q1 25 | $11.9M | $11.8M | ||
| Q4 24 | — | $12.3M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | $25.8M | $15.4M | ||
| Q1 24 | — | $10.9M |
毛利率HCMRVLV
| Q4 25 | 37.7% | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | 0.1% | 54.1% | ||
| Q1 25 | 48.0% | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | 41.1% | 54.0% | ||
| Q1 24 | — | 52.3% |
营业利润率HCMRVLV
| Q4 25 | -13.2% | 6.3% | ||
| Q3 25 | — | 7.1% | ||
| Q2 25 | -1.3% | 5.8% | ||
| Q1 25 | -5.0% | 5.0% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | -9.0% | 5.8% | ||
| Q1 24 | — | 3.4% |
净利率HCMRVLV
| Q4 25 | 0.7% | 5.7% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | 163.8% | 3.3% | ||
| Q1 25 | 3.7% | 4.0% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | 8.4% | 5.4% | ||
| Q1 24 | — | 4.0% |
每股收益（稀释后）HCMRVLV
| Q4 25 | $0.00 | $0.27 | ||
| Q3 25 | — | $0.29 | ||
| Q2 25 | $0.52 | $0.14 | ||
| Q1 25 | $0.01 | $0.16 | ||
| Q4 24 | — | $0.18 | ||
| Q3 24 | — | $0.15 | ||
| Q2 24 | $0.03 | $0.21 | ||
| Q1 24 | — | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $292.3M |
| 总债务越低越好 | $93.2M | — |
| 股东权益账面价值 | $1.2B | $512.5M |
| 总资产 | $1.8B | $765.0M |
| 负债/权益比越低杠杆越低 | 0.08× | — |
8季度趋势，按日历期对齐
现金及短期投资HCMRVLV
| Q4 25 | $1.4B | $292.3M | ||
| Q3 25 | — | $315.4M | ||
| Q2 25 | $1.4B | $310.7M | ||
| Q1 25 | $836.1M | $300.8M | ||
| Q4 24 | — | $256.6M | ||
| Q3 24 | — | $252.8M | ||
| Q2 24 | $802.5M | $244.7M | ||
| Q1 24 | — | $273.4M |
总债务HCMRVLV
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
股东权益HCMRVLV
| Q4 25 | $1.2B | $512.5M | ||
| Q3 25 | — | $490.2M | ||
| Q2 25 | $1.2B | $468.6M | ||
| Q1 25 | $759.9M | $453.4M | ||
| Q4 24 | — | $437.8M | ||
| Q3 24 | — | $420.8M | ||
| Q2 24 | $740.1M | $405.8M | ||
| Q1 24 | — | $389.9M |
总资产HCMRVLV
| Q4 25 | $1.8B | $765.0M | ||
| Q3 25 | — | $751.3M | ||
| Q2 25 | $1.8B | $722.9M | ||
| Q1 25 | $1.3B | $713.9M | ||
| Q4 24 | — | $665.5M | ||
| Q3 24 | — | $670.9M | ||
| Q2 24 | $1.3B | $657.8M | ||
| Q1 24 | — | $650.0M |
负债/权益比HCMRVLV
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $3.4M | $-13.3M |
| 自由现金流率自由现金流/营收 | 1.2% | -4.1% |
| 资本支出强度资本支出/营收 | 1.8% | 1.0% |
| 现金转化率经营现金流/净利润 | 4.21× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $-96.2M | $48.0M |
8季度趋势，按日历期对齐
经营现金流HCMRVLV
| Q4 25 | $8.2M | $-10.2M | ||
| Q3 25 | — | $11.8M | ||
| Q2 25 | $-72.9M | $12.6M | ||
| Q1 25 | $40.3M | $45.1M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | — | $9.1M | ||
| Q2 24 | $-39.8M | $-24.7M | ||
| Q1 24 | — | $38.4M |
自由现金流HCMRVLV
| Q4 25 | $3.4M | $-13.3M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | $-82.2M | $10.4M | ||
| Q1 25 | $32.5M | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $8.0M | ||
| Q2 24 | $-49.9M | $-25.7M | ||
| Q1 24 | — | $36.7M |
自由现金流率HCMRVLV
| Q4 25 | 1.2% | -4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | -29.6% | 3.4% | ||
| Q1 25 | 10.0% | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | -16.3% | -9.1% | ||
| Q1 24 | — | 13.5% |
资本支出强度HCMRVLV
| Q4 25 | 1.8% | 1.0% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | 3.3% | 0.7% | ||
| Q1 25 | 2.4% | 0.6% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | 3.3% | 0.4% | ||
| Q1 24 | — | 0.6% |
现金转化率HCMRVLV
| Q4 25 | 4.21× | -0.55× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | -0.16× | 1.24× | ||
| Q1 25 | 3.38× | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | -1.54× | -1.60× | ||
| Q1 24 | — | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HCM
暂无分部数据
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
